GlassScriptPhysician profile
Stephen Harmon Claycomb
NPI 1063592327
$1,033.77
in general payments reported to CMS, 2019-2025
16 companies · $382 in 2025
The $382 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.57 · 2021: $48.81 · 2022: $155 · 2023: $195 · 2024: $204 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $593.84 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $68.32 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Inspire Medical Systems, INC. | $54.62 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $53.34 | 2022-2025 | Rotarix, Pediarix, Bexsero |
| Supernus Pharmaceuticals, INC. | $33.91 | 2021-2023 | Qelbree |
| Cranial Technologies, INC | $31.48 | 2024-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $29.67 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $28.95 | 2020-2021 | |
| Noven Therapeutics, LLC | $20.08 | 2025 | Xelstrym |
| Sobi, INC | $19.27 | 2020 | |
| Verrica Pharmaceuticals INC. | $18.07 | 2024 | Ycanth |
| Tris Pharma INC | $17.53 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.32 | 2024 | Relexxii |
| Adlon Therapeutics L.P. | $16.77 | 2020 | |
| Cipher Pharmaceuticals US LLC | $15.81 | 2025 | Spinosad, Natroba |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Claycomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.